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Abstract 
 
Natural infection with Marek’s disease virus occurs through the respiratory mucosa after chickens inhale dander 
shed f r o m  infected  c h i c k e n s .  The  early  events  in  the  lung  following  exposure to  the  feather  and  
squamous epithelial  cell debris containing the viral particles  remain  unclear.  In order to elucidate the virological 
and immunological consequences of MDV infection for the respiratory tract, chickens were infected by 
intratracheal administration of infective dander. Differences between susceptible and resistant chickens were 
immediately apparent, with delayed viral replication and earlier onset of interferon (IFN)-g production in the 
latter. CD4
þ 
and CD8
þ 
T cells surrounded infected cells in the lung. Although viral replication was evident in 
macrophages, pulmonary B cells were the main target cel l  type in susceptible chickens following i n t r a t r achea l  
infection with MDV. In accordance, depletion of B cells curtailed viremia and substantially affected pathogenesis 
in susceptible chickens.  Together  the  data  described here  demonstrate the  role  of pulmonary B cells  as  the  
primary and predominant target  cells and  their  importance for MDV pathogenesis. 
 
 
Introduction 
 
arek’s disease ( MD) is a natural ly-occurring lymphomatous disease  that  afflicts susceptible genotypes 
of chicken a n d    other   species o f  poultry (54).  The  causative  agent,  Marek’s  disease  virus  ( MDV),  is a strictly  cell- 
associated a-herpesvirus (52) that shares many of its biological properties with  g-herpesviruses  such  as Epstein-Barr virus. 
Release of infectious cell-free virus from the feather follicle epithelium through shedding of feathers an d  sloughed skin flakes 
from infected chickens has been shown to be the mechanism by which MDV is spread (9, 18). Natural infection occurs through 
inhalation of this MDV-infective dander. Viral antigen   has  been  visualized in  lung  macrophages and  the virus  has been 
proposed to be taken  up  by lung  phagocytic cells, which could transport it to the lymphoid tissues where it replicates  in B and  
T lymphocytes (1). Experimental studies with cell-associated virus have been instrumental in characterizing MDV 
pathogenesis following intra-abdominal infection. The cell-associated virus is first detected in splenic lymphocytes and later in 
thymocytes and bursal cells, where it causes a lytic infection in lymphocytes from 3 d after infection (reviewed in 5). B cells have  
been  identified as the primary target  cells in these organs,  although T cells also become  lytically  infected  (7,17,50). After  the  
initial  round of cytolytic infection,   MDV  latently   infects  T  lymphocytes,  and   later CD4þ T cells become transformed, 
giving  rise to lymphomas in visceral  tissues  of susceptible chickens. The virus remains latent in resistant strains.  It is probably 
the latently-infected cells that carry the virus to the skin, where reactivation leads to productive infection in the feather follicle 
epithelium, completing the infectious c yc l e  (15). Genetics play a crucial role in disease outcome, and as such MHC has been 
shown to be a major contributor (3). However, despite s t r o n g  c o n t r i b u t i o n  of the MHC haplotype, other genes also 
contribute to resistance, as exemplified by line 6 and 7 strains that share the 
B2 locus (40). The susceptible line 7 chickens develop clinical 
MD, and have been shown t o  amplify t h e  virus to  a much higher level (6, 12). High levels of MDV particles persist in the 
feather follicle epithelium of susceptible as well as resistant chickens, and this cell-free virus continues to be shed, and is 
capable of initiating additional infectious cycles. 
Most studies of MDV pathogenesis have involved cell- associated MDV, and cell-free MDV or MD vaccines admin- mistered 
by a parenteral route. Although these approaches have elucidated the various phases o f  MD pathogenesis, inadvertently t h e y  
e x e m p t    crucial e v e n t s  t h a t  o c c u r  d i r e c t l y  a f t e r  natural MDV infection via the respiratory tract, and as a result little is 
known about this early phase. In the present study, we investigated early events after intratracheal infection to identify infected 
cells and the factors contributing to early MDV pathogenesis. The infection method used is reliable and allows precisely-timed, 
measurable dose of native MDV to be de- livered to the natural portal of entry. We show increased and earlier  viral  replication  
in  the  lungs   of  susceptible  line  7 chickens  compared to resistant line 6 chickens.  IFN-g expression in the lung increased 
after infection, but was delayed in susceptible chickens. The predominant target cells for viral replication are pulmonary B cells, 
although macrophages can also become infected later in the response. 
 
 
Materials and Methods 
 
Experimental animals 
 
 
Chickens   were  obtained from  parent flocks  of  outbred Rhode  Island  Red  (RIR), inbred  White  Leghorn  subline  72 (line 
7, MD-susceptible), or inbred  White Leghorn  subline  61 (line 6, MD-resistant), and maintained in disease-free  conditions  at the 
Institute for Animal  Health.  The parent flocks were  not  vaccinated and  tested  negative for antibodies to a range   of  poultry  
pathogens,  including  MDV,   infectious bursal  disease  virus  (IBDV), and  chicken  infectious  anemia virus (CIAV). Their 
progeny were free of maternal antibodies to MDV. Experimental birds we r e  housed in wire cages in isolation rooms entered 
through an air lock. Each room was provided with high efficiency particle air (HEPA)-filtered air under positive pressure. The 
rooms were hosed down daily to prevent the build-up of dander on the floor and w a l l s . Food a n d  w a t e r  w e r e  
a v a i l a b l e  a d  libitum throughout.  All animal procedures were performed in accordance with local ethical regulations, and 
were approved by the U.K. Home Office. Unless o therwise stated, t h e  chickens w e r e  2  wk.  of age when  infected  with  
MDV. 
 
Dander isolation for infecting chickens 
 
Thirty RIR chickens were infected by intra-abdominal injection of 1000 pfu of a very virulent strain of serotype-1 MDV, RB1B 
(46), from the 11th passage in primary chicken kidney cells. Three weeks after infection, dander was collected from the e x t r a c t  
f i l t e r s  o f  the i s o l a t i o n    room.   This dander  was coarsely f i l t e r e d  u s i n g  a  household flour sieve followed b y  
315-mm steel mesh, desiccated overnight and stored in 2-g quantities in sealed tubes below -708C. Control dander  was obtained 
from the extract filters of a similar room housing uninfected RIR chicks and treated in the same way. The same batches of dander 
were used for all of the experiments. 
 
Experimental design 
 
Known q u a n t i t i e s  of a suspension of dander were delivered into the lower trachea by carefully inserting the delivery tube 
of a PennCentury microaerosilizerTM (PennCentury, Philadelphia, PA) through the g l o t t i s  a n d  i n s u f f l a t i n g  the dander 
using 2 –3 mL of air.  Infected  chickens  were  killed when  clinical signs  of MD reached a predetermined  clinical end-point: 
unable  or reluctant to walk (paretic limbs), dis- interested in  food  or  water,   assuming a  hunched posture with  drooping 
wings  and  head,  displaying loss  of weight, and  cloudy  partially-closed eyes. 
 
Titration of infective dander 
 
The minimum infecting dose  of the batch of MDV-infective dander needed to induce c l i n i c a l  signs of MD was 
determined by insufflating a standard amount (5 mg) of dander containing different  proportions of the MDV-infective  material:  
5,  2.5,  1,  0.1,  0.01,  0.002,  or  0.001 mg  dose  (n ¼ 8). Another 8 chickens were treated with 5 mg of the uninfected dander. 
Blood  samples   (usually   50 mL)  were  obtained  by venipuncture at 3, 7, 10, 14, 21, 35, 48, and 62 d post-infection (dpi) to 
monitor MDV viremia  by quantitative PCR, and  on some  occasions  test  for antibodies against  IBDV and  CIAV by ELISA 
(Index, Westbrook, USA). The chickens were monitored for clinical signs of MD for 63 d, after which the experiment was 
t e r m i n a t e d . At  63 dpi  all  remaining birds were killed, and liver, heart, and brachial=sciatic  nerves were removed and fixed 
in buffered formaldehyde-saline (pH 7.5) prior  to histological  processing and  staining  with  hematoxylin  and  eosin.  Tissue  
sections  were  examined and  scored blindly   for  lymphocyte  infiltration  using   the   MD  lesion scoring  system  described by 
Burgess  et al. (13). 
 
Early events after natural infection 
 
Thirty chickens from each of the resistant (line 6) and susceptible (line 7) lines were infected by intratracheal insufflation   of 
2 .5  mg o f  dander.  Thirty   age-matched birds from  each  line  were  used  as  controls  and  given  2.5 mg  of noninfective 
dander  by  the  same  route.   Spleen  and  lung samples  were  collected  post  mortem from  six infected  and six uninfected 
chickens  of each  line at 1, 2, 3, 4, and  5 dpi. Leukocytes were i s o l a t e d    from t h e  sp l een  a n d  o n e  of the lungs from each 
chicken and isolated for analysis by flow cytometry and   for D N A =RNA   extraction.   The r e m a i n i n g  lung was removed and 
prepared for cryosectioning and immunostaining. 
 
Depletion of B cells and cell sorting after natural infection 
 
Sixty chicks from each of the resistant (line 6) and susceptible (line 7) lines were surgically bursectomized at day 18 of 
embryonation and allowed to hatch. At 2 wk of age, blood B-cell levels were checked, and only those whose B cells were 
depleted were infected by intratracheal insufflation of 2.5 mg of dander. In addition, an age-matched control g r o u p  was 
infected with  2.5 mg of dander. Blood samples ( 50 mL) were collected from the wing veins at 3, 7, 10, 16, 23, and 41 dpi for DNA 
i s o l a t i o n .   At  5  and  20 dpi,  spleens   (n ¼ 3)  were  re- moved  and  single-cell  suspensions were  stained with  CT4- FITC 
(CD4 cells), AV20-PE (B cells), AV14-AlexaFluor-646 (CD8  cells),  and   KUL-01-biotin=SA-PerCP   (macrophages). Cells were 
sorted fo u r  ways using a MoFlo (Dako Cytomation, Glostrup, Denmark), and RNA was extracted from the individual 
populations. 
 
Preparation of cell suspensions 
 
Spleens  were  extracted and  homogenized over cell sieves (Becton Dickinson,  Frnaklin  Lakes, NJ) and blood was drawn 
from  the  jugular  vein  using  a 23-gauge  needle.  Peripheral blood  leukocytes  (PBL), lung  leukocytes, and  spleen  leukocytes 
were  purified by density  gradient centrifugation using Ficoll-Paque  Plus (Amersham Pharmacia Biotech, Little Chalfont,  UK). 
Leukocytes were  prepared from  the  spleens by  passing  through a 70-mm  cell strainer,  and  lung  leukocytes  were  further   
purified by  enzymatic digestion of  the lung.  Briefly,  lungs   were  washed in  PBS and  injected  in several   places  with  a  
 
total  of  3–4 mL  of  enzyme  cocktail (556 mg=mL DNase I [Boehringer  Mannheim, Bracknell, U.K.] and   2.2 mg=mL  
collagenase  D  [Boehringer   Mannheim] in HBSS [Sigma,  Gillingham, U.K.]). After incubation at 378C for 15 min, t h e  f i r s t  
suspension was d i s c a r d e d .  Digestions were repeated until the lung tissue had completely disintegrated and subsequent 
cell suspensions were transferred to 
10 mm EDTA in HBSS without calcium.  The  collected  cell suspension was  filtered  using  a 70-mm cell strainer  and  layered  
onto  Ficoll-Paque  Plus. 
 
Quantification of MDV and cytokine transcripts 
 
The  amount of MDV  present in the  DNA  isolated  from PBL (DNeasyª 96 tissue  kit; Qiagen,  Crawley,  U.K.) was 
quantified using a real-time  quantitative PCR assay (TaqmanTM; Applied Biosystems,  Foster  City, CA) for the  MDV Meq 
gene,  essentially  as described by Kaiser et al. (33). Meq reaction  mixtures included primers and  probe  to  an  avian 
housekeeping  gene,   ovotransferrin  (Ovo), labeled   with   a second  fluorescent dye  (VICTM;  Applied Biosystems).  Raw data 
were normalized to a positive control included in every run to exclude plate-to-plate variation (14). 
Reverse transcription of isolated  RNA (RNeasyª 96 tissue kit;  Qiagen)   was   performed  using   a  single-tube  single- 
enzyme system  reaction  (Taqman  EZ RT-PCR Kit; Applied Biosystems),  essentially   as  described by  Kaiser  et al. (33). 
RNA was analyzed using primer and probe for cytokine transcripts (24) and viral transcripts (14). All cytokine=MDV reactions 
we r e  corrected fo r  the amount of cellular RNA by using 28S RNA (housekeeping gene) as described for quantitative PCR 
reactions. 
 
Isolation and quantification of MDV in dander 
 
DNA was extracted from 2.5 mg of infective dander and 1000 pfu cell-associated MDV for comparison of viral load. A sample  
(2.5 mg)  of the  dander was  added to  10 mL  of TE buffer   (1 mm  EDTA,  10 mm  Tris-HCl   [pH   8.0],  2%  v=v nonidet 
P40, and  0.05% v=v Tween-20)  and  incubated over- night, and after sonication (3x30 sec, Soniprep, London, UK), was 
digested in proteinase K (1 mg=mL) in 1% (w=v) SDS at 
458C  for 8 h. The  supernatant was  aspirated after  centrifugation  (300xg  for  5 min)  and  DNA  was  extracted using  a 
DNeasy  tissue kit (Qiagen).  Viral DNA was quantified using real-time quantitative PCR assay using the Meq gene. 
 
Fluorescent labeling of cell subsets and flow cytometry 
 
Immunofluorescent staining of leukocytes for flow cytometry analysis was used to quantify relative changes in lymphocyte 
subpopulations.  All a n t i b o d i e s  were   diluted 1:200 in PBS-BSA (0.4% w=v)-aside ( 0.1% w=v), and  1x106 leukocytes 
were stained with anti-CD8b-biotin (51), followed by streptavidin-APC (Southern Biotechnology Associates, Birmingham, 
AL).  Following   incubation, washing, and blocking  with  5% normal  mouse  serum,  the  cells were  incubated with  directly-
conjugated anti-chicken monoclonal antibodies CD4-FITC  (19), CD3-PE  (20), and  CD8a-PerCP (51). In separate tubes, 
duplicate samples were stained for macrophages (KUL-01) (37), followed by Ig (HþL)-FITC (Southern Biotechnology), and 
t h e n  B  cells (Bu1-PE) (43). Lymphocyte suspensions were analyzed using a  Fascial- bur (Becton-Dickinson) and FCSExpress 
software version 1.0 (DeNovo Software, Los Angeles, CA). 
 
Immunostaining of tissue sections 
 
Tissues  sections  (6 mm)  were  cut  using  a  cryostat  (Leica CM1900; Leica, Bannockburn, IL), air-dried overnight, and 
fixed  in  acetone  for  10 min.  Slides were s t o r e d    airtight   at -708C until immunohistochemistry. All antibodies were  diluted   
in  0.4%  (w=v)  BSA-PBS and   incubated  for  60 min. CD8aþ  T cells were  labeled  (AV14, 1:25) and  visualized using the 
Vectastain  Elite ABC kit (Vector Laboratories, Peterborough, U.K.), and the Vector NovaRed substrate kit (Vector 
Laboratories), according to the manufacturer’s instructions. Sections wer e  c o u n t e r s t a i n e d  with h e m a t o x y l i n  (Gill no.  
3; Sigma) and p e r m a n e n t l y  mounted in Clearium (Surgipath, Peterborough, U.K.). 
Cryosections for immuno flu orescen t  staining   were p r e - pared as above.  Nonspecific  reactivity was  blocked  by 
incubation   with   5%  (v=v)  normal   mouse   serum   for  20 min. Macrophages (KUL-01, 1:30) (37), B cells (Bu1, 1:200) (43), 
CD4þ cells (AV29, 1:30), and CD8aþ T cells (AV14, 1:25) were visualized by Alexa568-conjugated goat anti-mouse IgG H=L ( 
Molecular  Probes,  Eugene,  OR). Where in d icat ed , sections were double-stained with the viral protein pp38 using Alexa488-
conjugated BD1 (1:100) (36). Nuclei were stained by incubation with 1 .09  mM DAPI (Sigma) for 10 min.  Sections were mounted 
in Vectashield (Vector Laboratories) and analyzed using a confocal microscope (Leica SP2 with 405-, 488-, and 568-nm lasers).  
Control s e c t i o n s  were treated similarly, but were incubated with isotype control antibodies. 
 
Statistical analysis 
 
Mean lesion scores between multiple groups were com- pared using the Kruskal-Wallis test. Where an overall level of 
significance was observed, Dunn’s test was conducted to determine significance between groups. Mortality data were analyzed 
by the Kaplan a n d  Meier  method. Significance in viral load was analyzed using analysis of  variance fo l lowed  by Tukey’s test, 
where overall significance was observed. Statistical analysis was performed using Graphpad Prism software version 4 
(GraphPad Software, San Diego, CA). 
 
Results 
 
Intratracheal administration of MDV-infective dander to mimic the respiratory infection route 
 
An in fec t io n  m o d e l    was e s t a b l i s h e d  to study the e a r l y  events f o l l o w i n g  p u l m o n a r y  exposure to MDV 
 
particles i n  their natural form. Infective or control  dander were obtained from  the  extract  vents  of rooms  housing chickens  
either  infected  with  cell-associated RB1B virus  or  control  chickens, respectively. The dander consisted  of dried  sloughed 
flakes of  skin  and  fragments of  feather  barbules, and  contained small numbers of micrococci (gram-positive cocci in 
clusters) and    gram-negative   lactose-positive  and    lactose-negative rods  (data   not  shown).   Overall   there w e r e  n o  
majo r  d i f f e r e n c e s  between the two preparations. The presence of viral particles    in    the    infective    dander   was    
confirmed   by extracting MDV DNA and analysis  b y  real-time P C R  (data not shown).  Insufflating this material d e e p  in to  
the trachea 
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FIG. 1.   Natural infection of susceptible line 7 chickens with MDV induces morb id i ty  and pathology in a dose-dependent 
manner. Natural infection was titrated by intratracheal instillation of 5, 2.5, 1, 0.1, 0.01, 0.002, or 0.001 mg of RB1B-infective 
dander bulked up  to 5 mg with noninfective dander into susceptible line 7 chickens. Controls received  5 mg of noninfective 
dander. (A) Morbidity and time to reach the defined c l inical  end-points. (B) Mean lesion scores in heart, liver, and nerve as 
determined by histological scoring.  Values shown are means ± SEM (n ¼ 8) (*p < 0.05 difference from uninfected chickens on 
Kruskal-Wallis test). (C) Detection of MDV levels in PBL as measured by quantitative PCR after infection. Chickens receiving 
5 mg of noninfective dander were negative and are not shown.  Dots represent individual birds testing positive for virus for 
the first time, with the horizontal bar representing the mean value. 
 
 
 
using   a  dry-material  microaerosolizer appeared  to  cause only minor  interference with  respiratory function,  and  some 
nonspecific   inflammatory  changes   from  which   the  chicks quickly  recovered. Preliminary experiments using a range of doses 
( 2.5–20 mg) o f  MDV-infective   dander demonstrated that   susceptible R I R  c h i c k e n s    developed MD   (data   not shown).  
No clinical signs were observed when no nin fec t ive  dander was administered. After insufflation with either infective or 
noninfective dander, no clinical or serological manifestation of any other lymphotrophic virus (IBDV or CIAV) i n f e c t i o n    
was   observed.  MDV I C P 4  D N A    could readily be detected in PBL as early as 5 d after instillation of 
2.5–20 mg of dander. 
The initial experiments did no t  take into account t h e  inflammation caused by the bolus of dander administered and its 
potential effect on MD pathogenesis. Different doses of MDV-infective  dander were tested  for their ability to induce MD  in  
susceptible line  7 chickens  while  standardizing the total administered bolus, and 5 mg of total dander containing different   
ratios  of  MDV-infective  and  noninfective dander was administered to the chickens, which  were monitored for clinical  signs,  
MD  lesions,  and  viremia  (Fig. 1). More than 50% of chickens given  the higher d o s e s  of infective dander 
(1, 2.5, and  5 mg)  developed clinical  signs  of  MD  by  10– 12 dpi,  whereas these  were  significantly  ( p < 0.001) delayed in 
chickens given the lower doses (0.001, 0.002, and 0.01 mg), which  survived to the end  of the experiment at 63 dpi. 
Tissues removed post-mortem were examined for the presence o f  lymphoid lesions b y  histology. Histology was evaluated 
at the onset of clinical signs rather than at set time points.  All chickens  treated with  the MDV-infective  dander had  
significantly   ( p < 0.05) greater   lymphocyte  infiltration into the liver, heart, and nerve post-mortem compared to uninfected 
birds, but there was no clear evidence  that this infiltration was  dependent on the treatment dose  (Fig. 1B). 
MDV levels in PBL were determined by quantitative PCR assay.  Viral DNA w a s  n o t  d e t e c t e d  in the  s a m p l e s    from 
chickens   treated with   the n o n i n f e c t i v e  dander ( data   not shown).  The onset of a detectable viremia in infected groups 
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was d e l a y e d  in chickens g i v e n  s m a l l e r    doses o f  infective dander (Fig. 1C). MDV was  detected from 7 dpi  onwards 
in the chickens receiving  the higher  doses (5, 2.5, and 1 mg), but later  (from  21 dpi  onwards) in chickens  receiving  the  lower 
doses  of  MDV-infective  dander. In all future   experiments 
2.5 mg  of infective  dander was  used  for intratracheal  infection,  as this  dose  reliably  and  reproducibly induced MD in 
susceptible (line 7 and  RIR) chickens. 
 
 
Early viral replication in lung leukocytes of susceptible chickens 
 
The viral  events  during the  first 5 d after  pulmonary  exposure  to 2.5 mg MDV-infective  or noninfective dander were 
investigated in  chickens  susceptible and  those  resistant to
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FIG. 2.   Early MDV replication in lung and spleen after  natural infection.  Resistant  line 6 and  susceptible line 7 chickens 
were  infected  by intratracheal instillation of 2.5 mg  of RB1B-infective dander and  harvested daily  for 5 d. DNA  and  RNA 
were isolated  from lung and  spleen  leukocytes. (A) Viral load was assessed by the presence of Meq DNA using quantitative 
PCR. (B) Viral replication in leukocytes w a s  assessed b y  the expression of RNA transcripts of the early gene, pp38, using 
quantitative RT-PCR on DNase-treated RNA. Lung leukocytes are shown in the left graph and spleen leukocytes in the right 
graph. Values shown a r e  means ± SEM (n ¼ 6). Significance between infected group s :  **p < 0.01; ***p < 0.001. (C) Viral 
infection in lungs  at 5 dpi  was  visualized by confocal  microscopy of sections  that  were  stained for the viral  protein pp38,  
in susceptible (left panel)  and  resistant (right  panel)  lungs.  (scale bars ¼ 50 mm). 
 
 
 
MD. DNA w a s  i s o l a t e d    from l u n g  a n d  s p l e e n  l e u k o c y t e s  daily after insufflation and tested for the presence of the 
Meq gene as an indication of the viral load present (Fig. 2A). Viral DNA was detected as early as 2 dpi in lung leukocytes f ro m 
susceptible chickens, and was delayed by 1 d in the resistant chickens, and both increased with time. The earliest evidence of 
MDV in spleen leukocytes  was not until a day later in susceptible chickens,  at  3 dpi,  with  a 1-d  delay  in  the  leukocytes  from 
 
the resistant chickens. 
The  presence   of  MDV  genomes was  indicative of  viral particles,  but  did  not  demonstrate viral  replication.  There-fore, 
DNase-treated RNA  from  lung  and  spleen  leukocytes was analyzed by quantitative RT-PCR assay using specific primers and 
probes  for immediate early (ICP4), early (pp38), and  late (gB) gene transcripts. Viral RNA (pp38) was first detected in lung 
leukocytes o f  susceptible chickens at 2 dpi, and of resistant chickens a t  3 dpi (Fig. 2B). Similarly  to the viral load, detection 
of pp38 transcripts in spleen  leukocytes was delayed by 1 d compared with  the respective values  for the  lung  lymphocytes 
in  both  genotypes, which  increased with  time.  From t h e  time o f  detection, viral r e p l i ca t io n  in the r e s i s t a n t  leukocytes   
remained lower   than   that i n  t h e  susceptible leukocytes ( significance a t  5 dpi wa s  p  < 0.001). Similar pat t erns  were 
o b s e r v e d  for the GB and I C P 4  transcripts (data not shown). 
Viral replication was also evident when lung sections were stained for pp38 antigen using immunofluorescence (Fig. 2C). Five 
days after infection a substantial amount of viral antigen was p r e s e n t  in the lu n g s  o f  susceptible chickens, b u t  n o t  resistant 
chickens, confirming the results obtained using RT- PCR. 
 
 
Inflammatory cytokine transcript levels in lung and spleen leukocytes 
 
The effect of early viral replication on cytokine levels was assessed,   as t h e y  c o u l d    play   an i m p o r t a n t  role i n  M D V  
Pathogenesis. Transcripts for IFN-a, IFN-b, IFN-g, IL-4, IL-6, IL-18, and TGF-b in lung and splenic leukocytes w e r e  measured 
u s i n g  quant i tat ive  RT-PCR assay.  Intratracheal  infection   with   MDV  resulted  in  a  substantial  and   sustained increase  
in IFN-g transcripts as early as 3 dpi  in the lungs  of resistant chickens  compared to controls,  and  was delayed in the 
susceptible chickens  (Fig. 3A). No substantial differences based on either genotype or infection could be demonstrated for the 
other cytokines in lung leukocytes (data not shown). During  the  first  3 d  after  intratracheal infection,  there  was little effect on 
the transcript levels of any of the cytokines  in spleen  leukocytes  compared with  birds  treated with  noninfective dander (Fig. 
3). However, by 4 dpi  there  was  an  in- crease  (4–8 times)  in  the  transcript levels  of IFN-a,  IFN-b, IFN-g, IL-6, and IL-18 in 
susceptible leukocytes. This increase 
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FIG.  3.   Cytokine   transcript levels in  lung a n d  s p l e e n  l e u k o c y t e s    of resistant and s u s c e p t i b l e  birds a f t e r  
i n t r a t r a c h e a l  insufflation with RB1B-infective or control dander. (A) Chicken IFN-g transcripts were measured in RNA 
extracted from lung leukocytes or spleen leukocytes. (B) IFN-a, IFN-b, IL-6, and IL-18 transcripts in RNA from spleen 
leukocytes measured using quantitative RT-PCR. All cytokine data were corrected u s i n g  28s RNA levels. Values shown a re  
means ± SEM (n ¼ 6). 
 
 
Was also evident a t  5 dpi, especially fo r  IFN-g and IL-6, for which a 16-fold increase was observed (p < 0.01 and p < 0.05, 
respectively). In the resistant spleen leukocytes t h i s  increase was minimal even at 5 dpi, and was restricted to IL-6, IFN-g, 
and IL-18. The observed increase in  spleen leukocytes  f r o m  susceptible chickens   was   significantly   different   (p < 0.05) 
from that of resistant chickens.  No differences b as ed  on  genotype or infection were observed for either IL-4 or TGF-b in the 
spleen (data not shown).  Thus, susceptible chickens seem to have a delay in IFN-g production in the lung and a more profound 
inflammatory cytokine profile in the spleen. 
 
Increased CD8 T-cell population in the lung after infection 
 
The effect of intratracheal insufflation of infective dander on proportions and lo ca t ion  o f  lymphoid cells was invest igated  
using flow cytometry. The percentage of T cells, B cells, and macrophages in the lungs and spleens  o f  resistant and 
susceptible chickens during early viral replication was determined (Fig. 4). Overall,  infection  caused  a significant  in- crease  ( 
p < 0.01) in the ratio  of lymphocytes in the lungs  of both  genotypes from  4 dpi  onward, as  measured by  CD45 expression 
(data  not  shown).  In the lung, the proportion of CD3þCD8abþ   leukocytes   increased from 4  dpi a f t e r  i n s u f f l a t i o n  i n  the 
i n f e c t e d    compared to u n infec t ed  groups to around   fourfold    at   5 dpi    in   the    susceptible   chickens (p < 0.05). KUL-
01þ macrophages displayed a similar profile, increasing to twofold over the uninfected controls by day 5 (p < 0.05). Pulmonary 
B cells were unaffected in number and remarkably similar between the groups. In the spleen, the percentage of B cells was 
s i g n i f i c a n t l y    higher   in resistant versus susceptible chickens, with the opposite being demonstrated for T cells. Genotype 
appeared to affect the cellular 
Composition significantly   more i n  the spleen.  Other  differences were  restricted to a reduction in CD8abþ  T cells at 4 and  
5 dpi,  and  B cells  at  5 dpi  in  the  spleens   of  infected susceptible chickens. 
As the predominant change in cellular ratio was observed in lung CD8abþ T cells, the location of these cells following 
intratracheal infection was investigated using immunohistochemistry (Fig. 5). An increase in the proportion of CD8aþ 
pulmonary leukocytes was evident in both chicken lines following i n f e c t i o n .  The  number of positive  cells increased with  
time,  especially  in  susceptible chickens,  in  which  the CD8aþ  cells occupied a large  proportion of the  lung  from 
3 dpi onward. The CD8 T cells were usually located adjacent to pulmonary spaces. 
The spatial relationship between T cells and infected cells was investigated by immunofluorescence. No evidence of 
infected (pp38þ) CD8 T cells was observed. Even at 5 d after insufflation no co-localization of the pp38þ and CD8þ  cells could 
be distinguished (Fig. 5E). However, CD8þ T cells seemed to be surrounding the infected cells. A similar observation wa s  
made fo r  CD4þ T cells (Fig. 5F); after extensive searches no infected cells could be distinguished, even during the highest 
levels of infection at 5 dpi in susceptible chickens. 
 
Pulmonary B cells are primarily infected following MDV infection 
 
Although crucial for pathogenesis, the cell types that take up MDV in the lung following n a tu ra l  infection remain u n -
known. A potential role of macrophages in the uptake and propagation of the virus has been proposed (1, 8). In our 
experiments, macrophages were predominantly localized around the pulmonary spaces following i n t r a t r a c h e a l  infection 
(Fig. 6A and B). The potential role of macrophages as carriers o f  MDV was tested b y  immunofluorescent double- staining. 
Viral  pp38  antigen  was  observed in  a  small  percentage  of KUL-01þ  macrophages in the lungs  of susceptible chickens  at 5 
dpi,  but  this  was  by no means  a frequent  occurrence   (Fig.  6D). M a n y    non-macrophage-infected   cells were   present and   
were   proposed to b e  B  cells.  Double staining of infected cells for the viral antigen pp38 and the B- cell marker Bu1 showed 
that B cells were the predominant infected cell type in the lung following infection (Fig. 6E and F). Pp38-Specific staining o f  the 
infected cells was predominantly c y t o p l a s m i c , near the plasma membrane, and co u ld  be detected as early as 3 dpi. 
The role of B cells in the pathogenesis after natural infection was investigated by depleting all B cells using embryonic 
surgical b u r sec to mies . Resistant a n d  susceptible chicks were bursectomized at embryonic day 18 before the efflux of B cells 
into the periphery (reviewed in 53). Control fertilized eggs were set  under similar co n d i t i o n s . All chicks were al lowed to  
hatch and were infected by the intratracheal route at 2 wk of age. Bursectomized susceptible line 7 chickens had a s imi lar    
onset o f  clinical s i g n s  a s  i n t ac t  r e s i s t a n t  line 6  chickens (Fig. 7A). The resistant line 6 chickens that had been 
bursectomized were completely protected from any clinical signs for the duration of the experiment. These data were 
complemented by reduced viremia in the bursectomized chickens co mp ared  to their respective controls ( Fig. 7B). In the 
susceptible line 7 chickens viremia was  delayed. 
To identify  how  B cell depletion affected  pathogenesis, B cells, macrophages, and  CD4 and  CD8 T cells were  sorted from  
spleens  of chickens  infected  by the  natural route  at 5 and  20 dpi  (Fig. 7C and  D). MDV  replication was  demonstrated in B 
cells and macrophages at 5 dpi in susceptible but not  resistant chickens,  and  the  cell types  had  very  similar viral  loads  per  
cell. No viral replication was observed in T cells at this time point.  Depletion of B cells by bursectomy 
Prevented vi ra l    replication i n  K U L -01þ    macrophages   of susceptible chickens. At 20 dpi, predominantly CD4 and CD8 
T cells were infected in the bursectomized susceptible chickens.  No intact susceptible line 7 chickens remained for comparison 
a t    this   time   point.   Intact   resistant  chickens showed only  very  low  levels  of viral  replication in CD4 T cells, but  did  
not have  any  detectable levels of viral replication once bursectomized. 
 
 
 
Discussion 
 
MD, a lymphoproliferative disease o f chickens, is caused by a virus t h a t  i s  mainly s p r e a d  by contact e x p o s u r e . The 
ability to infect chickens via the respiratory tract has been demonstrated by studies performed as early as the 1970s; infection  
through contact   exposure with  airborne suspensions of infective  dander (1,9,15,31,32) and  with  infected  individuals 
(34,39,48), administration of feather  tip extracts (16,21), as well as cell-associated virus (38) were all shown  to cause  MD. 
However, some characteristics of these approaches, such as reproducibility issues, inability to deliver a quantifiable dose of virus, 
or delivery to  the gastrointestinal 
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FIG. 4.   Early changes in cell populations in the lungs and spleens following pulmonary infection. Single-cell analysis of lung 
and spleen leukocytes from resistant line 6 and susceptible line 7 chickens following pulmonary exposure to RB1B-infective or 
noninfective dander. CD8 T cells (A), CD4 T cells (B), B cells (C), or macrophages (D) were identified using flow cytometry 
and plotted as a ratio of the live cells. Values shown a re  means ± SEM (n ¼ 6). Significant differences between infected and 
control chicken is represented as follows: susceptible *p < 0.05, **p < 0.01, and resistant #p < 0.05. 
 
 
  
 
FIG. 5.   T-cell populations surround infected cells in the lung after intratracheal infection.  Lung  sections  from resistant (A 
and  B) and  susceptible (C and  D)  chickens  insufflated with  infective  (B and  D) or  control  (A and  C) dander were  
immunostained for CD8 antigen  4 d after insufflation. Some of the parabronchi are indicated by arrows and airways by ‘‘a.’’ 
The relationship of T cells to infected cells in susceptible lungs was visualized at 5 dpi with immunofluorescent double-
staining by confocal microscopy (E and F). Pp38þ-Infected cells (green) are surrounded by CD8 (E) and CD4 T cells (F) (red).  
White arrows indicate T  cells that are in very close proximity to infected cells (scale bars ¼ 50 mm). 
 
 
 
 
 
FIG.  6.   Viral replication in pulmonary B cells and m a c r o p h a g e s  of chickens a f t e r  in fection .  The effect of 
intratracheal infection on macrophages in the lung was assessed by immunohistology. Lungs were removed from control (A) or 
infected (B) chickens at 1 dpi and stained using KUL-01 antibody. The most intensely s t a i n e d  areas are depicted here.  Some 
of the parabronchi are indicated by arrows, a n d  a i r wa ys  by asterisks ( scale bar ¼ 50 mm).  B cells, macrophages, and  viral  
pp38 antigen  were  visualized in lung  sections  from susceptible line 7 chickens  at 3 and  5 dpi  by immunofluorescence. 
Shown are viral pp38 staining (green) co-stained with either macrophage marker KUL-01 (red) (C and D), or B cell marker Bu-
1 (red) (E and F), at 3 dpi (C and E) and 5 dpi (D and F). Nuclei were visualized with DAPI (blue). White arrows indicate 
infected cells (scale bars ¼ 10 mm).
 
 
Tract (1,9,29), precluded their use to investigate early events after infection.  The approach to deliver  infective  dander via the 
trachea  described here circumvents some of these issues, allowing for  the  exact  timing  of  events  following   pulmonary  
infection.  The microaerosolizer provides a simple  and effective  tool  to  introduce a  standard dose  of MDV  in  its native  
 
form  into  the  trachea  in a timed  manner. We previously demonstrated the importance of the route and the form of the  virus  
when  parenteral infection  with  cell-associated virus  was  compared to  intratracheal infection  with  native MDV  for  
resistant and   susceptible  strains   (14).  Although 2.5 mg  of dander contained 16 times  more  viral  DNA  com- pared to  1000 
pfu  of  cell-associated virus  (the  doses  used in the experiments), even increasing the infective dose of cell- associated virus  
100 times  could  not  replicate  the  timing  of the clinical signs seen after intratracheal infection  (14). In addition, preliminary 
data s u g g e s t  t h a t  the  form of the infective material is also crucial in determining clinical outcome (Staines and Butter, 
unpublished data).  These data highlight the importance of the route of infection for pathogenesis and eventual clinical 
outcome. 
Immune responses in line 6 and 7  genotypes have been  investigated by several researchers and were shown to influence the 
outcome of infection (reviewed in 38). Here, the immune response after natural infection was investigated by quantitative 
analysis of cytokine transcript levels and cell subpopulations. We  show  that  differences  between genetically  inbred  strains  
that  are  susceptible or resistant to MD tumor formation may  already be expressed during the early virological  events  in the 
pulmonary environment, and  could therefore  direct the ensuing pathogenesis. Viral replication could be detected as early as 2 
dpi in the lung leukocytes o f  susceptible chickens, whereas that in the spleen was delayed by 1  d.  Although  cell-associated 
MDV  was   reported  by Philips  and  Biggs  (41) at  24 h  following   natural  exposure infection,  the  length  of  contact  with  
the  infected  chickens (3 d) did  not allow  for the determination of the precise  time of infection  (e.g., 24 h after  the  end  of 
exposure could  actually be 4 d after initial infection).  The 1-d delay for detection of viral replication in the spleen could  be  a 
consequence of the transport of the virus from its site of entry.  Although it is not  clear  if transport occurs  through blood  or  
lymph,  Adldinger  and  Calnek  (1) reported virus  in  the  buffy  coat  of infected   chickens   as  early  as  18 h  after  infection.  
With a  limited   sensitivity o f  d e t e c t i o n , t h e s e    authors f a i l e d    to identify any early replication in the lung. In spleen  
and  lung leukocytes  of resistant birds  the  1-d delay  of detection and significantly  reduced viral  replication at 5 dpi  
suggests that resistance  is expressed at  the  replication level  at  this  early stage.  A  correlation between  viral  load  in  the  
blood  and tumor formation in line 6 and  7 chickens  has been reported, although this  was  much  later,  at  14 dpi  (12). That  
genetic resistance  manifests itself so early  with  respect  to viral  load is remarkable, and  the delay  and  lower viral load could  
be a distinct  advantage to the resistant line 6, as viral and  tumor load  are  correlated. The reduced viral replication could a l - 
low for more time to generate an effective immune response. For example, M D V -induced IFN-g in lung leukocytes o f  
resistant l i n e  6 chickens is concomitant with viral replication, but delayed in those of susceptible chickens.  The 2-d delay 
between viral replication and IFN-g production in lung leukocytes  of susceptible birds  could  provide a crucial  time  period  
for the  virus  to replicate  uncontrolled, as IFN-g is a potent   inhibitor  of  MDV  replication  (22,56). It is unclear what cell 
population produces the IFN-g in the resistant chickens; the influx of CD8 cells, potent s e c r e t o r s  o f  IFN-g, did not occur 
until 4 dpi. NK cells are a likely candidate and could poten t ia l ly  express IFN-g. The mapping of MD resistance in line 6 and  
7 chickens to the MDV1 locus (11), which shows  synteny to the Cmv1 locus that  controls  susceptibility to  infection  with  
mouse  cytomegalovirus and  maps  to  the mouse  NK gene  complex  (44), suggests a link  between genetic resistance  and  NK 
cell activity.  The importance of NK cells in MD pathogenesis was inferred  from genetically resistant  chickens  that  have  
earlier  and  stronger NK  cell response  in resistant (B21B21) compared to susceptible (B19B19) chickens  (26,28,49). However, 
these cells were not examined in our experiments. 
In  the  spleen,  IFN-g levels  correlated with  the  onset  of detectable viral replication and  were  higher  in leukocytes  of 
susceptible than  resistant chickens  at 4 and  5 dpi.  Temporal expression studies in r e s i s t a n t  chickens   (B21B21) have   
revealed that IFN-g transcription was upregulated in spleen extracts as early as 3 dpi following intra-abdominal infection with 
cell-associated virus (55). Similar to our data and those of Xing and Schat (55), Kaiser et al. (33) reported strong IFN-g 
expression during the first week of viral replication in splenocytes of chickens with the resistant B21B21 or B2B2 haplotype.  
However, the delay i n  IFN-g expression observed in susceptible B2B2 or B19B19 chickens in  our experiments was not 
evident. The viral load between line 6 and 7 splenocytes was also not significantly different in the very first week and at 
odds with the data reported here. Both could be a result of the infection route. The IFN-g response in the spleen  leukocytes  
corresponded with  an  overall  increase  in the  levels  of IFN-a, IFN-b, IL-6, and  IL-18 inflammatory cytokine  transcripts 4 
and  5 days after intratracheal infection  in susceptible birds.  Comparable changes f o r  IL-6 and I L -18 transcript levels 
between line 6 and 7 chickens have been described (33), although these were later i n  t h e  i n f e c t i o n .   Consistent  with   
earlier   hypotheses (4,35), a strong  increase  in cytokines  in the line 7 birds  suggests a more profound inflammatory 
response, which potentially could  attract  more  target  lymphocytes. Interestingly, type I IFNs are upregulated in the spleens 
of susceptible chickens following infection. Hong and Sevoian (30), reported the  opposite when  using  K and  S strain  
chickens, and  although a  bioassay  was  used  that  could  not  discern between IFN-a,  IFN-b,  or  IFN-g,  overall  this  was  
not  expected,  given  the antiviral role of the IFNs. 
Overall the differences we observed in the proportions of specific lymphocyte subpopulations in the spleen b e t w e e n  the 
genotypes (more B cells and fewer T cells in the resistant chickens, independent of infection) were not observed in the lung.  
Thus  a possible  role  for  cell numbers in  the  lung  to affect infection  potential and  influence  genetic  resistance,  as 
postulated for the spleen (35), is unlikely.  Infection caused  an increase  in  CD3þCD8abþ  T cells in  the  lungs  of both  
susceptible  and  resistant chickens  while  viral  replication was increasing. Although cytotoxicity  was  not  addressed in this 
experiment, a cytotoxic T-cell population capable  of lysing MDV-infected  target  cells is generated following  MDV vaccination  
of line 6 chickens  (35,42 and  B.J.G. Baaten,  unpublished    data).    A   decrease    in   the    CD3þCD8abþ     T-cell 
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FIG.  7.   Depletion of B cells delays vi remia  a n d  cl inical  symptoms after intratracheal infection.  Resistant a n d  
susceptible  chickens bursectomized (Box) at day 18 of embryonation or intact were infected at 2 wk of age. (A) Morbidity and 
time to reach predefined clinical end-points are shown ( see Materials a n d  M e t h o d s  section) (Bx n ¼ 6; control n  ¼ 10). (B) 
Changes in viremia over  time between intact and Bx chickens were measured by quantitative PCR for the Meq gene and the 
ratios are graphed here.  (C and D) B cells, macrophages ( Mac), and  CD4 or CD8 T cells were  fluorescently sorted  and  
ICP4 RNA transcripts were enumerated in purified populations using quantitative RT-PCR (n ¼ 3). Viral replication in 
subpopulations is shown fo r  5 dpi (C) and 20 dpi (D). The data shown a r e  representative of duplicate experiments. 
population in the spleen  coincided with  extensive  viral  replication  and  is most  likely a result  of cytolytic  infection. 
We  were  unable  to  find  infected  T cells  in  the  lung  or spleen  during the first 5 d. Flowcytometric  approaches have 
shown  that  as early  as 4 d after  intraperitioneal infection  T cells were  pp38þ  (7). The infection route may affect the cell 
tropism of the infection, and T cells may not become infected until after the 5 d investigated in our experiments. It has been 
postulated that phagocytic cells take up virus particles in the 
Lung and transport these to the lymphoid organs, where  in fect ion  of B and T cells occurs (1). Although infected  pulmonary  
macrophages  were   identified,  there   were   many KUL-01-negative  virus-positive cells present, and  thus  macrophages were  
not the predominant infected  cell type  in the lung. Nevertheless, these do seem to be able to support viral replication, as 
sorted spleen macrophages from susceptible chickens were positive for MDV mRNA, confirming a report by Barrow e t  al. (8). 
However, since  we  show  that  a fully productive infection  is already in progress in pulmonary B cells as early as 3 d after 
infection,  when  no infected  macro- phages can  be identified, it seems  unlikely  that  the  macro- phages are infected  first. 
Although B cells have  been shown to be the  primary target  cells in spleen  following  intraperitoneal  infection  with  cell-
associated virus,  to our knowledge this is the first time that they have been shown  to be infected in the lung after respiratory 
infection. Complete removal of B cells by surgical bursectomy before intratracheal infection greatly impacted pathogenesis, 
reducing viremia and clinical signs, especially in  susceptible line 7 chickens.  The substantial impact on pathogenesis is in 
accordance with results seen following parenteral infection with cell-associated virus (45). Further analysis of the cell types 
infected revealed that B cells and macrophages were infected, but that B-cell depletion did not only impact t h e  B-cell 
compartment, but also prevented viral replication in macrophages of susceptible chickens. The absence of any detectable viral 
replication in sorted populations from line 6 spleens may be due to a lower level being undetected, and due to the timing of the 
event. Whereas secondary effects of bursectomy cannot  be excluded, these data  suggest  that  infection  of B cells is required 
for macro- phage  infection,  and  provides more  evidence  for the B cells as  the  primary targets  for  MDV.  These  data  
confirm  and extend  earlier suggestions that MDV can replicate  in macrophages (8), but challenge  the paradigm that the 
macro- phage’s  role in the  pathogenesis is to transport MDV from the lung  to the lymphoid organs,  where  the cytolytic  
phase ensues.  Apparent differences b e t w e e n  resistant and susceptible chickens do not seem to stem from a difference i n  the 
number of target B cells, as these were consistent over time. It is more likely that pulmonary B cells from line 7 chickens are 
more susceptible on a per-cell basis compared to those from resistant chickens, as reported by Lee et al. (35). It is not clear from 
our data  whether B cells become  infected  directly,  as is the case for other lymphotrophic herpesviruses (i.e., Epstein- Barr  
virus),  or  through an  intermediate cell type,  such  as lung  epithelium. Several researchers (23, 41) have demonstrated that   
chicken   lung   epithelial   cells t h e m s e l v e s  can harbor MDV antigen .   Epithelial   cells  in  the  atria  and  infundibila have  
been  shown  to  phagocytose small  particles that  enter  parabronchi in other  avian  species  (47). It is possible that epithelial  
cells become  infected  while translocating viral  particles   from  the  air-side  of  the  lung  to  the  parenchyma.  Here, B cells 
could become infected directly by translocated viral particles, or indirectly through infected epithelial   cells.  Therefore  
genotypic variation at  this  level could  account  for the  difference  in viral  replication demonstrated, and  this is an area of 
great  interest. 
A better  understanding of the early events  following  natural  infection  with  MDV is crucial  to investigate the  possibilities  
of designing vaccines  that  block infection  (reviewed in  2 and  27). Whereas   current vaccines h a v e  b e e n  i n s t r u m e n t a l  in 
controlling disease, they target viral replication. Challenge  viruses   still  infect,  replicate   in,  and   are  shed by MD-
vaccinated chickens,  providing a reservoir of MDV pathotypes that can survive  vaccine-induced immune responses  and  are 
 
able to infect other chickens  (10). Epidemiological modeling studies predict that vaccines that target pathogen replication tend to 
drive the pathogen to increased virulence ( 25). In contrast, vaccines th at  in ter fere  a t  the infection stage, before amplification 
of the pathogen, may have a neutral or even negat ive  effect on the evolution of virulence. Knowledge of the cellular and 
molecular events in the lung immediately following natural  infection will aid in the eradication of the disease. 
 
Conclusion 
 
The data  described here  demonstrate that  there  is extensive  viral  replication in  the  lung  within   the  first  5 d  after 
intratracheal infection of susceptible chickens, which is complemented by an increase in inflammatory cytokines  and the arrival  
of CD8 T cells. These events are delayed by 1 d in the resistant chickens, a l though  interestingly, there i s  early increased and 
sustained IFN-g expression in the lungs.  Our findings   suggest   that p u l m o n a r y  B cells sustain this ear ly viral rep l icat ion , 
whereas only a small nu mber  of infected macrophages can be identified. 
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